StockData
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.28−0.23 (-6.55%)

Close on Nov 18, 2026Market cap $28.64MP/E –Yield –

BriaCell Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for BriaCell Therapeutics

BriaCell Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More BriaCell Therapeutics figures

See a number that looks wrong?